Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology
Luís Castelo-Branco, Ahmad Awada, George Pentheroudakis, José Luis Perez‐Gracia, Joaquı́n Mateo, Giuseppe Curigliano, Susana Banerjee, Rosa Giuliani, Florian Lordick, Andrés Cervantes, Josep Tabernero, Solange Peters
Abstract
Since the beginning of 2020, the coronavirus disease 2019 (COVID-19) pandemic has progressively affected millions of people worldwide and has brought many uncertainties for patients, health professionals, and policymakers. According to the World Health Organization (WHO), as of 3 June 2021, there were 171 222 477 confirmed cases of COVID-19, including 3 686 142 deaths.1
Topics & Concepts
PandemicCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineClinical trialCoronavirusIntensive care medicineFamily medicineDiseaseVirologyInternal medicineInfectious disease (medical specialty)OutbreakCOVID-19 and healthcare impactsEconomic and Financial Impacts of CancerHealthcare cost, quality, practices